Ülejõe neumad OÜ

Active Registry code 12701067 OÜ Tartu linn Registered 7 Aug 2014
Compare

Ülejõe neumad OÜ is a OÜ based in Tartu linn, registry code 12701067, status: active. Main activity: Manufacture of pharmaceutical preparations. Its annual report for 2025 shows revenue of €7 919 and 0 employees.

Turnover
—
State taxes
1 240 €
↑ 0.0% vs Q2 2026
Labour taxes
1 240 €
↑ 0.0% vs Q2 2026
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2025 7 919 €
    industry median 48 003 € · companies in the industry: 19
  • Net profit margin · 2025 15.7 %
    industry median 9.8 % · companies in the industry: 15

Taxes and turnover

Q2 2023 – Q3 2026
State taxes, € Q3 2026: 1 240 € · +0.0% vs Q2 2026
05001 0001 500Q2 2023 Company: 81 €Q2·23Q4 2023 Company: 1 327 €Q4·23Q2 2025 Company: 512 €Q2·25Q2 2026 Company: 1 240 €Q2·26Q3 2026 Company: 1 240 €Q3·2605001 0001 500Q2 2023 Company: 81 €Q2·23Q4 2023 Company: 1 327 €Q2 2025 Company: 512 €Q2·25Q2 2026 Company: 1 240 €Q3 2026 Company: 1 240 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — 1 240 1 240 —
Q2 2026 — 1 240 1 240 —
Q2 2025 — 512 — —
Q4 2023 — 1 327 1 325 —
Q2 2023 — 81 — —

Financials by year

2016 – 2025
Revenue, € 2025: 7 919 € · +4.2% vs 2024 · industry median 48 003 € · above 33% of the industry
010 00020 00030 00040 00050 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 0 € Industry median: 28 809 €20192020 Company: 920 € Industry median: 25 207 €20202021 Company: 4 955 € Industry median: 11 877 €20212022 Company: 3 615 € Industry median: 4 897 €20222023 Company: 5 649 € Industry median: 3 851 €20232024 Company: 7 598 € Industry median: 25 284 €20242025 Company: 7 919 € Industry median: 48 003 €2025010 00020 00030 00040 00050 0002018 Company: — Industry median: —2019 Company: 0 € Industry median: 28 809 €20192020 Company: 920 € Industry median: 25 207 €2021 Company: 4 955 € Industry median: 11 877 €20212022 Company: 3 615 € Industry median: 4 897 €2023 Company: 5 649 € Industry median: 3 851 €20232024 Company: 7 598 € Industry median: 25 284 €2025 Company: 7 919 € Industry median: 48 003 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 1 247 € · +177.5% vs 2024 · industry median 676 € · above 55% of the industry
-2 000-1 00001 0002 0003 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -156 € Industry median: 2 812 €20192020 Company: 623 € Industry median: 97 €20202021 Company: -658 € Industry median: 0 €20212022 Company: 2 007 € Industry median: 0 €20222023 Company: 1 386 € Industry median: 0 €20232024 Company: -1 610 € Industry median: 0 €20242025 Company: 1 247 € Industry median: 676 €2025-2 000-1 00001 0002 0003 0002018 Company: — Industry median: —2019 Company: -156 € Industry median: 2 812 €20192020 Company: 623 € Industry median: 97 €2021 Company: -658 € Industry median: 0 €20212022 Company: 2 007 € Industry median: 0 €2023 Company: 1 386 € Industry median: 0 €20232024 Company: -1 610 € Industry median: 0 €2025 Company: 1 247 € Industry median: 676 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 15.7 % · +36.9 pp vs the year before · industry median 9.8 % · above 57% of the industry
-40-2002040602016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: — Industry median: 10.2 %20192020 Company: — Industry median: 7.1 %20202021 Company: -13.3 % Industry median: 1.4 %20212022 Company: 55.5 % Industry median: -1.9 %20222023 Company: 24.5 % Industry median: 4.4 %20232024 Company: -21.2 % Industry median: 1.2 %20242025 Company: 15.7 % Industry median: 9.8 %2025-40-2002040602018 Company: — Industry median: —2019 Company: — Industry median: 10.2 %20192020 Company: — Industry median: 7.1 %2021 Company: -13.3 % Industry median: 1.4 %20212022 Company: 55.5 % Industry median: -1.9 %2023 Company: 24.5 % Industry median: 4.4 %20232024 Company: -21.2 % Industry median: 1.2 %2025 Company: 15.7 % Industry median: 9.8 %2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 3 779 € · +28.5% vs 2024
01 0002 0003 0004 0005 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 1 829 €20192020 Company: 3 309 €20202021 Company: 1 851 €20212022 Company: 2 712 €20222023 Company: 4 016 €20232024 Company: 2 941 €20242025 Company: 3 779 €202501 0002 0003 0004 0005 0002018 Company: —2019 Company: 1 829 €20192020 Company: 3 309 €2021 Company: 1 851 €20212022 Company: 2 712 €2023 Company: 4 016 €20232024 Company: 2 941 €2025 Company: 3 779 €2025
Equity, € 2025: 3 598 € · +53.0% vs 2024
-1 00001 0002 0003 0004 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: -296 €20192020 Company: 327 €20202021 Company: -331 €20212022 Company: 2 576 €20222023 Company: 3 961 €20232024 Company: 2 351 €20242025 Company: 3 598 €2025-1 00001 0002 0003 0004 0002018 Company: —2019 Company: -296 €20192020 Company: 327 €2021 Company: -331 €20212022 Company: 2 576 €2023 Company: 3 961 €20232024 Company: 2 351 €2025 Company: 3 598 €2025
Employees 2025: 0 · industry median 28 · above 2% of the industry
0102030402016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: —20182019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.520202021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 3220242025 Company: 0 Industry median: 2820250102030402018 Company: 0 Industry median: —2019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.52021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —2023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 322025 Company: 0 Industry median: 282025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 7 919 1 247 0 3 779 3 598 0
2024 7 598 -1 610 0 2 941 2 351 0
2023 5 649 1 386 3 325 4 016 3 961 0
2022 3 615 2 007 0 2 712 2 576 0
2021 4 955 -658 4 988 1 851 -331 0
2020 920 623 — 3 309 327 0
2019 0 -156 — 1 829 -296 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
15.7 %
Net profit / revenue
Return on equity (ROE)
34.7 %
Net profit / equity
Return on assets (ROA)
33.0 %
Net profit / assets
Equity ratio
95.2 %
Equity / assets
Debt ratio
4.8 %
Liabilities / assets
Current ratio
20.86
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 1 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 2 Apr 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 4 Mar 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 8 May 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 20 May 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 30 Mar 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 30 Jun 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 21201Manufacture of pharmaceutical preparations Main
Rulings
Number, date Title Deadline State Document
Ä 20068470 / 8
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 20068470 / 7
9 Dec 2022
Amendment entry In force
9 Dec 2022
PDF
Ä 20068470 / M1
7 Dec 2022
Ruling to eliminate deficiencies 21 Dec 2022 Deficiencies eliminated
9 Dec 2022
PDF
Ä 20068470 / 6
8 Nov 2022
Amendment entry In force
8 Nov 2022
PDF
Ä 20068470 / 5
13 Jul 2020
Amendment entry In force
13 Jul 2020
PDF
Ä 20068470 / 4
19 Jan 2018
Amendment entry In force
19 Jan 2018
PDF
Ä 20068470 / 3
19 Dec 2017
Amendment entry In force
19 Dec 2017
PDF
Ä 20068470 / 2
7 Dec 2017
Amendment entry In force
7 Dec 2017
PDF
Ä 20068470
7 Aug 2014
First entry In force
7 Aug 2014
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data